Researchers have identified a mechanism that could help explain how ketamine helps relieve symptoms of depression.
Metformin, a common diabetes medication, shows promise for the treatment of anxiety and depression.
Researchers reports doxycycline, a common antibiotic, could help to disrupt the formation of negative memories associated with PTSD.
A new study reports those who microdose psychedelics report improvements in attention and mental health. However, a number of people report an increase in neuroticism following six weeks of microdosing.
A new study reports ketamine may be a safe and effective method of treating depression in older people. The University of New South Wales study reveals ketamine was well tolerated by those with depression, and repeated treatments led to a higher likelihood of remission.
MDMA shows promise for the treatment of post-traumatic stress disorder. Combining the use of Ecstasy with psychotherapy treatments resulted in a reduction of PTSD symptoms after just one session. 54% of the study participants no longer met the PTSD criteria after two sessions. Patients also reported improvements in depression symptoms.
Months after receiving psilocybin treatments for depression, patients report feeling more connected with nature and experience a shift away from authoritarian political views, researchers report.
Psychostimulant use in young adults is correlated with an increased risk of stroke.
Topiramate, a drug used to treat migraine headaches and epilepsy, could also help treat cocaine addiction, a new study reports.
Researchers explore the mechanisms behind ketamine's effectiveness at treating depression. The study reports the long lasting effects of ketamine may be due to G proteins timing in moving back to lipid rafts.
From treating depression and other mental health disorders, to helping relieve chronic pain, researchers discuss the advantages and implications of psychedelic treatments.
SSRI's, ketamine, and tricyclic antidepressants all bind with TrkB. The findings challenge the roles serotonin and glutamate receptors play in the effects of antidepressant medications.
